Sterling Pharma Solutions, a provider of small molecule API development and manufacturing services intended to serve the pharmaceutical industry, agreed to acquire Alcami Wisconsin, a pharmaceuticals company, for c. $19m. "This is the latest step of our strategic growth plans. It will ensure we continue to provide a strong transatlantic API presence to support our customers," Kevin Cook, Sterling Pharma Solutions CEO.